The American Society for the Prevention of Cruelty to Animals reports that in 2021, it helped over 401,000 animals affected by seasonal accidents and risks.
This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...